Main Page

Corporate Mission

CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics.
CureLab Oncology is committed to creating a family of revolutionary therapies for oncology patients in order to help prolong their lives.

Our Lead Product

Our lead product is an anti-cancer DNA vaccine, Elenagen™, which is effective against a
broad spectrum of primary tumors and metastatic processes. We believe, Elenagen™
is the only anti-cancer biological, which combines two mechanisms of action,
stimulating anti-cancer immunity and mitigating chronic inflammation.